The lower fee comes as big device makers lobbied hard against the proposed $40 million fee, enlisting senators in their home states of Minnesota, California, Massachusetts and elsewhere.
The original reform bills in the U.S. House did not have a device fee, but House Democrats are now devising an excise tax on medical devices, to be paid at the point of sale, that would yield a total of $20 billion between 2013 and 2019.
Read the Wall Street Journal’s report on the proposed medical device fee.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.